Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought

cafead

Administrator
Staff member
  • cafead   Oct 02, 2023 at 10:42: AM
via Genetic medicines biotech Lexeo Therapeutics and immune-focused French company Abivax both filed for their initial public offerings on Friday. Neither company specified how much they were seeking to raise in their respective SEC filings.

article source
 

<